Description
The abstract shows OPTN suppresses RIPK1-dependent signaling by regulating its turnover, but the specific molecular mechanisms are not explained. Understanding this regulation is critical for developing targeted therapeutic interventions that could modulate RIPK1 activity without broad immunosuppression.
Gap type: unexplained_observation Source paper: RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. (None, None, PMID:27493188)
Evidence summary
{“resolution_pipeline”: “scidex.atlas.gap_closure_pipeline”, “task_id”: “f4f7b129-0f43-4c84-abd8-20d4e701842d”, “evaluated_at”: “2026-04-28T19:10:30.894709+00:00”, “resolution_summary”: “Resolved by hypothesis h-d2d37a81eeaa: ACSL4 lipid remodeling creates ferroptosis-prone ALS membranes. Supporting evidence includes debate sess_SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918.”, “match_counts”: {“hypothesis_matches”: 2, “debate_matches”: 5, “paper_matches”: 0}, “hypothesis_matches”: [{“id”: “h-d2d37a81eeaa”, “title”: “ACSL4 lipid remodeling creates ferroptosis-prone ALS membranes”, “score”: 0.252, “reason”: “5 token overlaps; entity overlap: als”, “analysis_id”: “SDA-2026-04-26-gap-ferroptosis-mnd-768eaeba1be3”, “target_gene”: “ACSL4”, “target_pathway”: “PUFA phospholipid remodeling”, “disease”: “neurodegeneration”, “composite_score”: 0.7100000000000001, “confidence_score”: 0.685, “status”: “proposed”, “pubmed_evidence_ids”: [“29916020”, “31185581”, “38891021”, “38967083”, “38989463”]}, {“id”: “ec8b839c-6440-45dc-aff6-5edea1fd2d6d”, “title”: “STMN2 Cryptic Exon Inclusion is the Earliest Loss-of-Function Marker of TDP-43 Nuclear Depletion in ALS Motor Neurons”, “score”: 0.248, “reason”: “6 token overlaps; entity overlap: als”, “analysis_id”: “0ed3c364-07fd-4620-8e90-8bd33c14e370”, “target_gene”: “TARDBP”, “target_pathway”: “TDP-43 splicing regulation / axon maintenance”, “disease”: “ALS”, “composite_score”: 0.720856, “confidence_score”: 0.6, “status”: “open”, “pubmed_evidence_ids”: [“30643292”, “34879411”, “34930382”, “36927019”, “38967083”]}], “debate_matches”: [{“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “title”: “The authors evaluate several ALS-associated mutations in OPTN’s leucine-zipper domain but don’t fully explain how these mutations mechanistically lead to disease pathogenesis. Understanding this link is critical for developing targeted ALS therapies.\n\nGap type: unexplained_observation\nSource paper: Molecular Basis of the Recognition of the Active Rab8a by Optineurin. (2024, Journal of molecular biology, PMID:39374890)”, “score”: 0.725, “reason”: “14 token overlaps; entity overlap: als, optn, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-183548-043c7918”, “quality_score”: 0.95, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c_task_9aae8fc5”, “title”: “The abstract identifies that neurons show resistance to autophagy induction, but the mechanistic basis remains incompletely defined. Understanding this resistance is crucial for developing neuron-targeted autophagy therapies for ALS.\n\nGap type: unexplained_observation\nSource paper: Autophagy and ALS: mechanistic insights and therapeutic implications. (2022, Autophagy, PMID:34057020)”, “score”: 0.594, “reason”: “12 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-07-gap-pubmed-20260406-062212-ca78691c”, “quality_score”: 0.65, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88_20260413-225852”, “title”: “The study shows VCP-mutant astrocytes exhibit hypoxia response activation without actual hypoxia, but the mechanistic link between VCP dysfunction and HIF-1α stabilization remains unexplained. Understanding this connection is critical for developing targeted therapies that could prevent early pathogenic events in VCP-ALS.\n\nGap type: unexplained_observation\nSource paper: Hypoxic stress is an early pathogenic event in human VCP-mutant ALS astrocytes. (2026, Stem cell reports, PMID:41349534)”, “score”: 0.59, “reason”: “14 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-13-gap-pubmed-20260410-170057-1bea7d88”, “quality_score”: 0.78, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2_20260416-033018”, “title”: “The abstract shows p53 is a central regulator of C9orf72-mediated neurodegeneration but doesn’t explain how poly(PR) specifically activates p53. Understanding this upstream trigger mechanism is critical for developing targeted therapeutic interventions.\n\nGap type: unexplained_observation\nSource paper: p53 is a central regulator driving neurodegeneration caused by C9orf72 poly(PR). (None, None, PMID:33482083)”, “score”: 0.563, “reason”: “15 token overlaps; entity overlap: pmid”, “analysis_id”: “SDA-2026-04-15-gap-pubmed-20260411-090658-7651c1d2”, “quality_score”: 0.61, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}, {“id”: “sess_SDA-2026-04-14-gap-pubmed-20260410-184155-2ff305ca”, “title”: “The abstract reveals FUS has a chaperone-like function regulating TAZ condensate dynamics, but doesn’t address how FUS mutations in ALS/FTD might disrupt this function. This gap is critical since FUS mutations cause neurodegeneration, yet this newly discovered role in transcriptional regulation remains unexplored in disease context.\n\nGap type: open_question\nSource paper: A chaperone-like function of FUS ensures TAZ condensate dynamics and transcriptional activation. (None, None, PMID:38172614)”, “score”: 0.544, “reason”: “11 token overlaps; entity overlap: als, pmid”, “analysis_id”: “SDA-2026-04-14-gap-pubmed-20260410-184155-2ff305ca”, “quality_score”: 0.81, “status”: “completed”, “target_artifact_id”: null, “target_artifact_type”: null}], “paper_matches”: []}